HTGM Key Statistics, Chart & Performance
The current stock price of HTGM is 0.48 USD. In the past month the price decreased by -81.32%. In the past year, price decreased by -92.79%.
HTGM Technical Analysis
HTGM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HTGM. HTGM may be in some trouble as it scores bad on both profitability and health.
HTGM Financial Highlights
Over the last trailing twelve months HTGM reported a non-GAAP Earnings per Share(EPS) of -18.15. The EPS increased by 44.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 7.1 |
HTGM Forecast & Estimates
7 analysts have analysed HTGM and the average price target is 6.12 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 0.48.
For the next year, analysts expect an EPS growth of 81.55% and a revenue growth 0.6% for HTGM
HTGM Ownership
HTGM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 20.99 | 31.346B | ||
| DOCS | DOXIMITY INC-CLASS A | 18.99 | 6.637B | ||
| WAY | WAYSTAR HOLDING CORP | 14.61 | 4.59B | ||
| HTFL | HEARTFLOW INC | N/A | 2.396B | ||
| CERT | CERTARA INC | 13.29 | 1.212B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 229.95 | 1.102B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.083B | ||
| SDGR | SCHRODINGER INC | N/A | 984.098M | ||
| TDOC | TELADOC HEALTH INC | N/A | 870.788M | ||
| PHR | PHREESIA INC | 19.7 | 768.645M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HTGM
Company Profile
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. The company is headquartered in Tucson, Arizona and currently employs 53 full-time employees. The company went IPO on 2015-05-06. The firm is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The firm is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and from sample processing services. Its HTG EdgeSeq profiling technology measures ribonucleic acid (RNA) using deoxyribonucleic acid (DNA) nuclease protection probes (DNA protection probes). Its profiling product and service solutions enable targeted RNA profiling using a small amount of biological sample, in liquid or solid forms. Its menu of HTG EdgeSeq assays includes the HTG Transcriptome Panel (HTP), which is designed to measure approximately 20,000 mRNA targets using its HTG EdgeSeq technology, is automated on its HTG EdgeSeq system.
Company Info
HTG MOLECULAR DIAGNOSTICS
3430 E Global Loop
Tucson ARIZONA 85706 US
CEO: John L. Lubniewski
Employees: 53
Phone: 18772892615.0
HTG MOLECULAR DIAGNOSTICS / HTGM FAQ
What does HTG MOLECULAR DIAGNOSTICS do?
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. The company is headquartered in Tucson, Arizona and currently employs 53 full-time employees. The company went IPO on 2015-05-06. The firm is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The firm is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and from sample processing services. Its HTG EdgeSeq profiling technology measures ribonucleic acid (RNA) using deoxyribonucleic acid (DNA) nuclease protection probes (DNA protection probes). Its profiling product and service solutions enable targeted RNA profiling using a small amount of biological sample, in liquid or solid forms. Its menu of HTG EdgeSeq assays includes the HTG Transcriptome Panel (HTP), which is designed to measure approximately 20,000 mRNA targets using its HTG EdgeSeq technology, is automated on its HTG EdgeSeq system.
What is the stock price of HTG MOLECULAR DIAGNOSTICS today?
The current stock price of HTGM is 0.48 USD. The price decreased by -20% in the last trading session.
Does HTG MOLECULAR DIAGNOSTICS pay dividends?
HTGM does not pay a dividend.
How is the ChartMill rating for HTG MOLECULAR DIAGNOSTICS?
HTGM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the growth outlook for HTG MOLECULAR DIAGNOSTICS?
The Revenue of HTG MOLECULAR DIAGNOSTICS (HTGM) is expected to grow by 0.6% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.